There are documented incidences of new malignant gliomas and malignant progression of ANs after focused radiotherapy using either SRS or FRT for benign intracranial lesions.
While formerly, preservation of hearing during treatment was very unlikely, the newer techniques of microsurgery and stereotactic radiotherapy have enabled the preservation of functional hearing in the majority of cases.